Drug Development

2 researchers across 2 institutions

2 Researchers
2 Institutions
0 Grant PIs
0 High Impact

Research in drug development focuses on the discovery, design, and evaluation of new therapeutic agents. Investigations encompass understanding disease mechanisms at a molecular level, identifying potential drug targets, and synthesizing novel compounds. This work involves preclinical studies to assess drug efficacy, safety, and pharmacokinetic properties, often utilizing advanced analytical techniques and computational modeling. Areas of exploration include developing treatments for neurological disorders, metabolic conditions, and other diseases with significant public health impact.

This research holds relevance for Arkansas by addressing health challenges and fostering economic growth. Developing new pharmaceuticals can lead to improved patient outcomes for conditions prevalent in the state, potentially reducing healthcare burdens. Furthermore, advancements in drug development can support the growth of the state's biotechnology and pharmaceutical sectors, creating opportunities for innovation and high-skill employment.

This field draws on expertise from neuroscience, toxicology, metabolism, and genetics. Collaboration extends across multiple institutions within Arkansas, facilitating a comprehensive approach to therapeutic innovation.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Manan Nath UAMS 4 66
Shivangi Shrimali NCTR 2 13
Neurological Disorders And Treatments 1 Child And Adolescent Health 1 Epilepsy Research And Treatment 1 Emergency And Acute Care Studies 1 Metabolism And Genetic Disorders 1 Neuroscience And Neuropharmacology Research 1 Pharmacological Effects And Toxicity Studies 1 Microphysiological Systems 1 Phytochemicals And Antioxidant Activities 1 Microrna In Disease Regulation 1 Disease Models, Animal 1

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
4,883 works in 2025
-2.3% CAGR 2018–2025
Leadership concentration
8.5% held by global top 5 institutions
Fragmented HHI 45
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 Johns Hopkins University 3,465
  2. 2 Harvard University 3,414
  3. 3 National Institutes of Health 3,137
  4. 4 University of California, San Francisco 2,866
  5. 5 University of North Carolina at Chapel Hill 2,514
Browse All 2 Researchers in Directory